BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Australia

Precision Medicine Takes Center Stage: Exploring the Innovative Biopharma Industry in Australia and New Zealand

Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...

February 24, 2023 | News

Chrysalis Advisory and TriNetX collaborate to aid research teams in Australia and New Zealand

The goal of the collaboration is to extend the availability of consulting services to healthcare organizations in the region who are in need of assistance ...

February 22, 2023 | News

GNOMIX: Australian Study Uses MGI's DNBSEQ™ Platforms to Make Genomics Applications Accessible to All

Currently the clinical genomics landscape in Australia is strongly influenced by a couple of major players heavily driven by profit to provide a ...

February 17, 2023 | News

Inventia Life Science collaborates with MSD to develop 3D advanced cell models

Collaboration to develop 3D in vitro models of the brain for the discovery of therapeutic candidates using Inventia's novel 3D cell culture platform, RASTR...

February 16, 2023 | News

Putting Australian clinical research on the map globally, comes the ground-breaking first-in-human clinical trial for KIO-301.

In collaboration with US-based Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) and The Royal Adelaide Hospital, leading Australian CRO, Accelagen, is prou...

February 15, 2023 | News

STADA builds on Movapo heritage to offer Australian Parkinson’s patients new option

Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...

February 13, 2023 | News

AcuraBio expands cGMP plasmid DNA CDMO services with Cytiva

AcuraBio selects Cytiva's latest two-step purification protocol to offer a productive plasmid DNA service to its customers globally to alleviate supply c...

February 10, 2023 | News

Halucenex Life Sciences Inc. targets Australian market following landmark TGA decision

Creso Pharma Limited (ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences...

February 09, 2023 | News

Microba and BioAgilytix announce partnership to fast-track therapeutic delivery

Enables innovators to confidently leverage microbiome endpoints in clinical trials Delivers superior outcomes for clients at each stage of the d...

February 09, 2023 | News

Orion Health reinforces security credentials with HITRUST and DirectTrust accreditations

Orion Health, a global leader in population health software, today announced that it has gained leading security credentials for two of its flagship produc...

February 08, 2023 | News

Tavneos® (avacopan) approved in Australia for the treatment of ANCA-associated vasculitis

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos&r...

February 07, 2023 | News

Psychedelic-Assisted Therapies Allowed in Australia Through Special Access Scheme

As the funder and sponsor of the most advanced research of a psychedelic-assisted therapy, MAPS is encouraged to see a fourth nation provide access to some...

February 06, 2023 | News

Australia Allows Prescription of MDMA and Psilocybin in Groundbreaking Regulatory Change

PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA) applauds the Australian Therapeutic Goods Administration (TGA) in allowing for spec...

February 03, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

February 03, 2023 | News

Stay Connected